Projects per year
Description
Within this project nucleic acid based vaccine strategy – in particular self-amplifying mRNA vaccine (SAM)- has been investigated since such platform was previously reported to elicit protective immune responses, particularly in the case of cell-mediated response in a safe manner and for a variety of virus disease. In order to enhance biological stability and cell internailsation, SAM was combined with four cationic delivery systems. Oil-in-water cationic nanoemulsions (CNE), polymeric nanoparticles (NPs), lipid nanoparticles (SLNs) and liposomes were formulated in absence or in combination with a specific SAM vaccine. Despite the difference in formulation composition, all samples contained the same concentration of cationic lipid - 1, 2-dioleoyl-3-trimethylammonium-propane (DOTAP), or dimethyldioctadecylammonium (DDA) - known as immunostimulants.
| Date made available | 25 Feb 2020 |
|---|---|
| Publisher | University of Strathclyde |
| Date of data production | 2 Jan 2017 - 17 Nov 2019 |
Projects
- 1 Finished
-
Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines PHA-ST-TRAIN-VAC (H2020 MCSA EID)
Perrie, Y. (Principal Investigator)
European Commission - Horizon Europe + H2020
1/06/16 → 31/05/20
Project: Research